Approvals/TGA/ELOCTATE efmoroctocog alfa (rhu) 250 IU powder for injection vial and diluent pre-filled syringe

Approved

STANDARD

ELOCTATE efmoroctocog alfa (rhu) 250 IU powder for injection vial and diluent pre-filled syringe

Sanofi-Aventis Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 09e07cd9b6835e24
Product Name: ELOCTATE efmoroctocog alfa (rhu) 250 IU powder for injection vial and diluent pre-filled syringe
Artg Id: 210521
Artg Name: ELOCTATE efmoroctocog alfa (rhu) 250 IU powder for injection vial and diluent pre-filled syringe
Sponsor: Sanofi-Aventis Australia Pty Ltd
Company Detail Path: /organization/sanofi-aventis-australia-pty-ltd
Artg Date: 2014-06-27
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/94fc5f93a7fccaf064951154a8b92a50.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/efce60d6ee9660856ac614b4051d1f2f.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

09e07cd9b6835e24

Type

Standard